L293-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonamido]acetamide

L293-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonamido]acetamide
L293-0151 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L293-0151
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L293-0151

Molecular Formula

C20H20N4O6S (C20 H20 N4 O6 S)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonamido]acetamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-2-[2-methyl-5-(5-methyl-124-oxadiazol-3-yl)benzenesulfonamido]acetamide

SMILES

Cc1nc(-c2cc(S(NCC(Nc(cc3)cc4c3OCCO4)=O)(=O)=O)c(C)cc2)no1

InChI

InChI=1S/C20H20N4O6S/c1-12-3-4-14(20-22-13(2)30-24-20)9-18(12)31(26,27)21-11-19(25)23-15-5-6-16-17(10-15)29-8-7-28-16/h3-6,9-10,21H,7-8,11H2,1-2H3,(H,23,25)

InChI Key

PVTCHKVCXDDUJR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27241598

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.47

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.153

Distribution Coefficient, logD

2.150

Water Solubility, LogSw

-2.93

Polar Surface Area

111.874

Acid Dissociation Constant (pKa)

9.54

Base Dissociation Constant (pKb)

1.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

L293-0151 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Others
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L293-0151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L293-0151?
Check Price and Availability of L293-0151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L293-0151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L293-0151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L293-0151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L293-0151 available by request